http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6509019

Outgoing Links

Predicate Object
contentType Journal Article|Review
endingPage 602
issn 1744-8301
1479-6694
issueIdentifier 5
pageRange 591-602
publicationName Future oncology (London, England)
startingPage 591
bibliographicCitation Navari RM. Palonosetron: a second-generation 5-hydroxytryptamine receptor antagonist. Future Oncol. 2006 Oct;2(5):591–602. doi: 10.2217/14796694.2.5.591. PMID: 17026451.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf75dd6931e314441e4b9f1da566c317
date 200610
identifier https://pubmed.ncbi.nlm.nih.gov/17026451
https://doi.org/10.2217/14796694.2.5.591
isPartOf https://portal.issn.org/resource/ISSN/1479-6694
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32856
https://portal.issn.org/resource/ISSN/1744-8301
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Palonosetron: a second-generation 5-hydroxytryptamine receptor antagonist
discusses http://id.nlm.nih.gov/mesh/M0221985
http://id.nlm.nih.gov/mesh/M0018359
http://id.nlm.nih.gov/mesh/M0019685
http://id.nlm.nih.gov/mesh/M0001391
http://id.nlm.nih.gov/mesh/M0006099
http://id.nlm.nih.gov/mesh/M0011785
http://id.nlm.nih.gov/mesh/M0544719
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D012702Q000627
http://id.nlm.nih.gov/mesh/D058831
http://id.nlm.nih.gov/mesh/D007546Q000627
http://id.nlm.nih.gov/mesh/D011812Q000627
http://id.nlm.nih.gov/mesh/D000932Q000627
http://id.nlm.nih.gov/mesh/D000971Q000009
http://id.nlm.nih.gov/mesh/D009325Q000517
hasSubjectTerm http://id.nlm.nih.gov/mesh/D012307
http://id.nlm.nih.gov/mesh/D003907Q000627
http://id.nlm.nih.gov/mesh/D011812Q000009
http://id.nlm.nih.gov/mesh/D017322
http://id.nlm.nih.gov/mesh/D007546Q000009
http://id.nlm.nih.gov/mesh/D000932Q000009
http://id.nlm.nih.gov/mesh/D012737
http://id.nlm.nih.gov/mesh/D009325Q000139
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D017326
http://id.nlm.nih.gov/mesh/D000077924
http://id.nlm.nih.gov/mesh/D000367
http://id.nlm.nih.gov/mesh/D012702Q000009
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4595
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6337614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cd71d115a35cee8c7d4dec9b713a0583

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128482492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136064078
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136177720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136224371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129095671

Total number of triples: 63.